Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Vox Sanguinis|February 18, 2009
A report on transmissible spongiform encephalopathies and transfusion safetyJ Coste, C Prowse, R Eglin, et al.Vox Sanguinis|January 1, 1987
Studies on the procurement of blood coagulation factor VIII in vitro studies on blood components prepared in half-strength citrate anticoagulantC Prowse, Y G Waterston, J Dawes, et al.Transfusion|February 13, 2001
The release of prion protein from platelets during storage of apheresis plateletsH Bessos, O Drummond, C Prowse, et al.Acta Haematologica|January 1, 1995
In vivo models of thrombogenic potential: usefulness and limitationsI MacGregor, L McLaughlin, O Drummond, et al.Vox Sanguinis|March 17, 2010
A pilot study of the possibility and the feasibility of haemoglobin dosing with red blood cells transfusionH Reikvam, C Prowse, H Roddie, et al.Vox Sanguinis|January 1, 1985
A diffusable factor in Scottish coagulation factor concentrates can inhibit lymphocyte transformation in vitroC McDonald, V Jackson, D C Kilpatrick, et al.Journal of Immunological Methods|March 10, 1989
Human atrial natriuretic factor (ANF). Characterisation of a monoclonal antibody panel and its use in radioimmunoassayC Prowse, E George, L R Micklem, et al.Journal of Internal Medicine|January 22, 2008
Acceptability of blood and blood substitutesE Ferguson, C Prowse, E Townsend, et al.Scandinavian Journal of Clinical and Laboratory Investigation|July 22, 1998
Analysis of peptides derived from Pro Atrial Natriuretic Peptide that circulate in man and increase in heart diseaseE F Macaulay Hunter, P A Kelly, C Prowse, et al.Transfusion Medicine (Oxford, England)|December 15, 2010
Evaluation of noninvasive methods for the estimation of haemoglobin content in red blood cell concentratesH Reikvam, L van de Watering, C Prowse, et al.Pageof 3